A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy

A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy

Backgrounds: The purpose of this paper is to investigate the prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters in patients treated with concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC). Methods: Studies that...

Full description

Bibliographic Details
Main Authors:	Lu Han, Qi Wang, Lanbo Zhao, Xue Feng, Yiran Wang, Yuliang Zou, Qiling Li
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Diagnostics
Subjects:	positron-emission tomography prognosis uterine cervical neoplasms meta-analysis chemoradiotherapy
Online Access:	https://www.mdpi.com/2075-4418/11/7/1258

Similar Items

Prediction of Neoadjuvant Chemoradiotherapy Response in Rectal Cancer with Metric Learning Using Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography
by: Kuo-Chen Wu, et al.
Published: (2021-12-01)

Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy
by: Jinju Oh, et al.
Published: (2019-05-01)

Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
by: Erkan Topkan, et al.
Published: (2020-11-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
by: Kazuhiro Suzumura, et al.
Published: (2017-12-01)

Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer
by: Yiyan Liu
Published: (2013-09-01)

Spontaneous ureteral rupture during concurrent chemoradiotherapy in a woman with uterine cervical cancer
by: Shun-ichi Ikeda, et al.
Published: (2015-08-01)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
by: Feiya Shi, et al.
Published: (2022-03-01)

Diagnostic errors of coronavirus infection: Role of fluorodeoxyglucose positron emission tomography/computed tomography scan
by: Abtin Doroudinia, et al.
Published: (2020-01-01)

Clinical utility of 18fluorodeoxyglucose positron emission tomography-computed tomography in rheumatology
by: Sirisha Kommireddy, et al.
Published: (2021-01-01)

18F-Fluorodeoxyglucose positron emission tomography may not visualize radiation pneumonitis
by: Meiying Guo, et al.
Published: (2019-12-01)

An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma
by: Noriyuki Okonogi, et al.
Published: (2022-08-01)

Positron emission tomography scan reveals an unusual source for cervical lymphadenopathy: Right colon cancer
by: Silvia Palmisano, et al.
Published: (2011-01-01)

Diagnostic and prognostic value of preoperative ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography
by: Joo Young Lee, et al.
Published: (2017-04-01)

Recurrent Proliferating Trichilemmal Tumor with Malignant Change on the F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Eun Ha Moon, et al.
Published: (2016-06-01)

Positron emission tomography and positron emission tomography-computerized tomography in pediatric patients
by: Patel Chetan, et al.
Published: (2007-01-01)

Asymptomatic Thymic Carcinoma With Solitary Hepatic Metastasis Detected by Fluorodeoxyglucose Positron Emission Tomography
by: Lien-Yen Wang, et al.
Published: (2009-08-01)

Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography‐staged esophageal squamous cell carcinoma after complete resection: A population‐based cohort study
by: Hsin‐Yuan Fang, et al.
Published: (2022-07-01)

Diagnostic Role of F-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Restaging of Upper Urinary Tract Urothelial Carcinoma
by: Hakan Öztürk
Published: (2017-09-01)

Frequency of skeletal metastasis on 18F-fluorodeoxyglucose positron emission tomography/computed tomography with negative computed tomography at Institute of Nuclear Medicine and Oncology
by: Mariam Fayyaz, et al.
Published: (2022-11-01)

Diagnostic utility of positron emission tomography-computed tomography and indications for 18F-Fluorodeoxyglucose and amyloid-tracers
by: Maria Lucia Calcagni, et al.
Published: (2018-11-01)

The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis
by: Silvia Taralli, et al.
Published: (2012-01-01)

Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study
by: Yan-Mei Liu, et al.
Published: (2018-01-01)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
by: Raminta Stuopelytė, et al.
Published: (2023-04-01)

Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Mio Mori, et al.
Published: (2021-07-01)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
by: Weiping Wang, et al.
Published: (2017-08-01)

18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging evaluation of chorea
by: Nobuyuki Ishii, et al.
Published: (2018-09-01)

Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma
by: Takuto Matsuura, et al.
Published: (2021-03-01)

Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy
by: Chad A. Barnes, et al.
Published: (2020-04-01)

18F‐fluorodeoxyglucose‐positron emission tomography/computed tomography delineates involved sites in the cervical spine in Langerhans cell histiocytosis
by: Shinsaku Imashuku, et al.
Published: (2022-08-01)

Use of F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Rare Head and Neck Cancers
by: Jong-Lyel Roh, et al.
Published: (2008-06-01)

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy
by: Christine Gennigens, et al.
Published: (2020-11-01)

The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma
by: Athanasios Bantis, et al.
Published: (2016-01-01)

Does Diabetes Mellitus Influence Standardized Uptake Values of Fluorodeoxyglucose Positron Emission Tomography in Colorectal Cancer?
by: Da Yeon Oh, et al.
Published: (2014-04-01)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
by: Igor Sirák, et al.
Published: (2008-01-01)

18F fluorodeoxyglucose positron-emission tomography–computed tomography in the diagnosis of brachial plexopathy in carcinoma breast
by: Suma Tammineni Medara, et al.
Published: (2022-01-01)

Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography
by: Yoko Satoh, et al.
Published: (2019-11-01)

Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings
by: Hakan Öztürk
Published: (2015-01-01)

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy
by: Cheng Ming, et al.
Published: (2023-10-01)